Nicholas Andrew Saunders

Nicholas Andrew Saunders

Auto-generated profile, based on publicly available information

Nicholas Andrew Saunders

University of Queensland, Woolloongabba, QLD, Australia

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2012 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
NSNicholas A. Saunders
Nicholas A. Saunders
FSFiona Simpson
Fiona Simpson
ETErik Walter Thompson
Erik Walter Thompson
Michelle HillMichelle Hill
Michelle Hill
LELiliana Endo‐Munoz
Liliana Endo‐Munoz
AGAlexander Guminski
Alexander Guminski
Drug resistance continues to be a major barrier to the delivery of curative therapies in cancer. Historically, drug resistance has been associated with over‐expression of drug transporters, changes in drug kinetics or amplification of drug targets. However, the emergence of resistance in patients treated with new‐targeted therapies has provided new insight into the complexities underlying cancer drug resistance. Recent data now implicate intratumoural heterogeneity as a major driver of drug resistance. Single cell sequencing studies that identified multiple genetically distinct variants within human tumours clearly demonstrate the heterogeneous nature of human tumours. The major contributors to intratumoural heterogeneity are (i) genetic variation, (ii) stochastic processes, (iii) the microenvironment and (iv) cell and tissue plasticity. Each of these factors impacts on drug sensitivity. To deliver curative therapies to patients, modification of current therapeutic strategies to include methods that estimate intratumoural heterogeneity and plasticity will be essential.

1 March 2020 in Cell
Verified
Journal Article
Closed access
HCHui Yi Chew
Hui Yi Chew
PLPriscila O. De Lima
Priscila O. De Lima
Jazmina Libertad Gonzalez CruzJazmina Libertad Gonzalez Cruz
Jazmina Libertad Gonzalez Cruz
BBBlerida Banushi
Blerida Banushi
GEGodwins Echejoh
Godwins Echejoh
FSFiona Simpson
Fiona Simpson

3 August 2009 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
SPSophie Paquet-Fifield
Sophie Paquet-Fifield
HSHolger Schlüter
Holger Schlüter
ALAmy Li
Amy Li
TATara Aitken
Tara Aitken
PGPradnya Gangatirkar
Pradnya Gangatirkar
PKPritinder Kaur
Pritinder Kaur
The cellular and molecular microenvironment of epithelial stem and progenitor cells is poorly characterized despite well-documented roles in homeostatic tissue renewal, wound healing, and cancer progression. Here, we demonstrate that, in organotypic cocultures, dermal pericytes substantially enhanced the intrinsically low tissue-regenerative capacity of human epidermal cells that have committed to differentiate and that this enhancement was independent of angiogenesis. We used microarray analysis to identify genes expressed by human dermal pericytes that could potentially promote epidermal regeneration. Using this approach, we identified as a candidate the gene LAMA5, which encodes laminin α5, a subunit of the ECM component laminin-511/521 (LM-511/521). LAMA5 was of particular interest as we had previously shown that it promotes skin regeneration both in vitro and in vivo. Analysis using immunogold localization revealed that pericytes synthesized and secreted LAMA5 in human skin. Consistent with this observation, coculture with pericytes enhanced LM-511/521 deposition in the dermal-epidermal junction of organotypic cultures. We further showed that skin pericytes could also act as mesenchymal stem cells, exhibiting the capacity to differentiate into bone, fat, and cartilage lineages in vitro. This study suggests that pericytes represent a potent stem cell population in the skin that is capable of modifying the ECM microenvironment and promoting epidermal tissue renewal from non-stem cells, a previously unsuspected role for pericytes.

15 November 1992 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
KMK W Marvin
K W Marvin
MGM D George
M D George
WFW Fujimoto
W Fujimoto
NSN A Saunders
N A Saunders
SBS H Bernacki
S H Bernacki
Anton JettenAnton Jetten
Anton Jetten
In this study, we have characterized the cDNA clone SQ37 that was isolated previously from a rabbit squamous cell library. The gene encodes a 14-kDa protein that appears to function as a component of the cross-linked envelope in squamous differentiating cells. The protein, which has been named cornifin, has a high content of proline (31%), glutamine (20%), and cysteine (11%) and contains 13 repeats of an octapeptide (consensus sequence, EPCQPKVP) at its C terminus. SQ37 mRNA and protein are induced during squamous differentiation of rabbit tracheal (RbTE) cells and human epidermal keratinocytes. This induction is repressed by retinoids. Immunohistochemical studies reveal SQ37 immunoreactivity in fragmented cross-linked envelopes from squamous-differentiated RbTE cells and in the suprabasal layers of the epidermis. In situ hybridization analysis showed that the presence of SQ37 mRNA is restricted to the suprabasal layers. Treatment of RbTE cells with a Ca2+ ionophore induces cross-linking of the SQ37 protein into higher molecular weight complexes. This cross-linking reaction appears to be mediated by transglutaminase type I. Our observations suggest that the protein encoded by SQ37 participates in the assembly of the cross-linked envelope.

5 July 2004 in Oncogene
Verified
Journal Article
Closed access
ABAndrew Burgess
Andrew Burgess
ARAstrid Ruefli
Astrid Ruefli
HBHeather Beamish
Heather Beamish
RWRobyn Warrener
Robyn Warrener
NSNicholas Saunders
Nicholas Saunders
Brian GabrielliBrian Gabrielli
Brian Gabrielli

30 June 2006 in Cancer Gene Therapy
Verified
Journal Article
Closed access
WGW Gu
W Gu
LPL Putral
L Putral
KHK Hengst
K Hengst
KMK Minto
K Minto
NSN A Saunders
N A Saunders
NMNigel McMillan
Nigel McMillan